ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026)
ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | ARS Pharmaceuticals | 576.91 Mn | 375.94 Mn | - | 112.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.56% |
| Dec 31, 2025 | 131.24% |
| Sep 30, 2025 | 43.42% |
| Jun 30, 2025 | 69.03% |
| Mar 31, 2025 | 74.51% |
| Dec 31, 2024 | 85.71% |
| Sep 30, 2024 | 36.63% |
| Jun 30, 2024 | 7.07% |
| Mar 31, 2024 | 5.48% |
| Dec 31, 2023 | 74.47% |
| Sep 30, 2023 | 4,013.33% |
| Jun 30, 2023 | -76.10% |
| Mar 31, 2023 | -75.97% |
| Dec 31, 2022 | 356.94% |
| Sep 30, 2022 | -99.21% |
| Jun 30, 2022 | 25.25% |
| Mar 31, 2022 | 51.59% |
| Dec 31, 2021 | -95.55% |